Compare · DGX vs UNH
DGX vs UNH
Side-by-side comparison of Quest Diagnostics Incorporated (DGX) and UnitedHealth Group Incorporated (UNH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DGX and UNH operate in Medical Specialities (Health Care), so they compete in similar markets.
- UNH is the larger of the two at $355.98B, about 13.2x DGX ($26.99B).
- UNH has been more active in the news (7 items in the past 4 weeks vs 6 for DGX).
- Both have 25 recent analyst ratings on file.
- Company
- Quest Diagnostics Incorporated
- UnitedHealth Group Incorporated
- Price
- -
- -
- Market cap
- $26.99B
- $355.98B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 6
- 7
- Recent ratings
- 25
- 25
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Latest DGX
- Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference
- Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com
- Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
- Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology
- WHOOP Makes Advanced Labs Available Without a Wearable Membership
- Quest Diagnostics Declares Quarterly Cash Dividend
- Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics
- SVP & Chief Commercial Officer Delaney Mark E sold $376,288 worth of shares (1,600 units at $235.18) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 10,335 units (SEC Form 4)
- SVP, Clinical Solutions Kuppusamy Karthik increased direct ownership by 0.27% to 13,557 units (SEC Form 4)
- Director Carter Robert B increased direct ownership by 0.29% to 3,864 units (SEC Form 4)
Latest UNH
- Chief Executive Officer, Optum Conway Patrick Hugh sold $455,910 worth of shares (1,169 units at $390.00), decreasing direct ownership by 7% to 15,328 units (SEC Form 4)
- UnitedHealthcare Expands Access to Child and Family Behavioral Coaching to 13 Million Commercial Members
- Chief Accounting Officer Stankiewicz Dennis Andrew covered exercise/tax liability with 233 shares, decreasing direct ownership by 2% to 10,058 units (SEC Form 4)
- UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
- SEC Form 10-Q filed by UnitedHealth Group Incorporated
- Chief Executive Officer, Optum Conway Patrick Hugh sold $205,000 worth of shares (500 units at $410.00), decreasing direct ownership by 3% to 16,497 units (SEC Form 4)
- SEC Form SCHEDULE 13G filed by UnitedHealth Group Incorporated
- UnitedHealth Group Partners with UT Health Sciences to Expand Health Hubs to More Communities Across Tennessee
- UnitedHealth upgraded by Robert W. Baird with a new price target
- UnitedHealth Group Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits